Effective adjunctive therapy by an innate defense regulatory peptide in a preclinical model of severe malaria

AH Achtman, S Pilat, CW Law, DJ Lynn… - Science Translational …, 2012 - science.org
Case fatality rates for severe malaria remain high even in the best clinical settings because
antimalarial drugs act against the parasite without alleviating life-threatening inflammation …

Effective adjunctive therapy by an innate defense regulatory Peptide in a preclinical model of severe malaria

A Achtman, S Pilat, C Law, D Lynn… - Science …, 2012 - researchnow.flinders.edu.au
Case fatality rates for severe malaria remain high even in the best clinical settings because
antimalarial drugs act against the parasite without alleviating life-threatening inflammation …

[引用][C] Effective Adjunctive Therapy by an Innate Defense Regulatory Peptide in a Preclinical Model of Severe Malaria

AH Achtman, S Pilat, CW Law, DJ Lynn… - Science Translational …, 2012 - cir.nii.ac.jp
Effective Adjunctive Therapy by an Innate Defense Regulatory Peptide in a Preclinical Model
of Severe Malaria | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …

Effective adjunctive therapy by an innate defense regulatory peptide in a preclinical model of severe malaria

AH Achtman, S Pilat, C Law… - Science …, 2012 - researchonline.jcu.edu.au
Case fatality rates for severe malaria remain high even in the best clinical settings because
antimalarial drugs act against the parasite without alleviating life-threatening inflammation …

Effective adjunctive therapy by an innate defense regulatory peptide in a preclinical model of severe malaria

AH Achtman, S Pilat, CW Law… - Science …, 2012 - pubmed.ncbi.nlm.nih.gov
Case fatality rates for severe malaria remain high even in the best clinical settings because
antimalarial drugs act against the parasite without alleviating life-threatening inflammation …

[PDF][PDF] Effective Adjunctive Therapy by an Innate Defense Regulatory Peptide in a Preclinical Model of Severe Malaria

AH Achtman, S Pilat, CW Law, DJ Lynn, L Janot… - researchgate.net
Case fatality rates for severe malaria remain high even in the best clinical settings because
antimalarial drugs act against the parasite without alleviating life-threatening inflammation …

[PDF][PDF] Effective Adjunctive Therapy by an Innate Defense Regulatory Peptide in a Preclinical Model of Severe Malaria

AH Achtman, S Pilat, CW Law, DJ Lynn, L Janot… - academia.edu
Case fatality rates for severe malaria remain high even in the best clinical settings because
antimalarial drugs act against the parasite without alleviating life-threatening inflammation …

Effective adjunctive therapy by an innate defense regulatory peptide in a preclinical model of severe malaria

AH Achtman, S Pilat, CW Law… - Science …, 2012 - research.sahmri.org.au
Case fatality rates for severe malaria remain high even in the best clinical settings because
antimalarial drugs act against the parasite without alleviating life-threatening inflammation …

Effective adjunctive therapy by an innate defense regulatory peptide in a preclinical model of severe malaria.

AH Achtman, S Pilat, CW Law, DJ Lynn… - Science Translational …, 2012 - europepmc.org
Case fatality rates for severe malaria remain high even in the best clinical settings because
antimalarial drugs act against the parasite without alleviating life-threatening inflammation …

[PDF][PDF] Effective Adjunctive Therapy by an Innate Defense Regulatory Peptide in a Preclinical Model of Severe Malaria

AH Achtman, S Pilat, CW Law, DJ Lynn, L Janot… - med-fom-cbr.sites.olt.ubc.ca
Case fatality rates for severe malaria remain high even in the best clinical settings because
antimalarial drugs act against the parasite without alleviating life-threatening inflammation …